- NAYA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
NAYA Biosciences (NAYA) CORRESPCorrespondence with SEC
Filed: 2 Aug 23, 12:00am
August 2, 2023
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Re: | INVO Bioscience, Inc. | |
Registration Statement on Form S-1 | ||
File No. 333-273174 |
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC, as placement agent, hereby joins the request of the Company that the effective date of the above-captioned Registration Statement be accelerated so as to permit it to become effective on Thursday, August 3, 2023, at 5:30 p.m., ET, or as soon thereafter as practicable.
MAXIM GROUP LLC | ||
By: | /s/ Clifford A. Teller | |
Name: | Clifford A. Teller | |
Title: | Co-President |